カテゴリー： Market Monitor Global, 世界, 医療/バイオ

組換え活性型凝固第VII因子の世界市場見通し2023年-2029年

◆英語タイトル：Recombinant Activated Coagulation Factor VII Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8627 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：78 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Recombinant Activated Coagulation Factor VII Market 調査レポートは次の情報を含め、グローバルにおけるの組換え活性型凝固第VII因子市場規模と予測を収録しています。・世界の組換え活性型凝固第VII因子市場：売上、2018年-2023年、2024年-2029年
・世界の組換え活性型凝固第VII因子市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の組換え活性型凝固第VII因子市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「バイアル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

組換え活性型凝固第VII因子のグローバル主要企業は、Novo Nordisk、 LFB SA HEMA Biologics、 AryoGen Pharmedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、組換え活性型凝固第VII因子のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の組換え活性型凝固第VII因子市場：タイプ別、2018年-2023年、2024年-2029年
世界の組換え活性型凝固第VII因子市場：タイプ別市場シェア、2022年
・バイアル、プレフィルドシリンジ

世界の組換え活性型凝固第VII因子市場：用途別、2018年-2023年、2024年-2029年
世界の組換え活性型凝固第VII因子市場：用途別市場シェア、2022年
・血友病A、血友病B、その他

世界の組換え活性型凝固第VII因子市場：地域・国別、2018年-2023年、2024年-2029年
世界の組換え活性型凝固第VII因子市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における組換え活性型凝固第VII因子のグローバル売上、2018年-2023年
・主要企業における組換え活性型凝固第VII因子のグローバル売上シェア、2022年
・主要企業における組換え活性型凝固第VII因子のグローバル販売量、2018年-2023年
・主要企業における組換え活性型凝固第VII因子のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novo Nordisk、 LFB SA HEMA Biologics、 AryoGen Pharmed

*************************************************************

・調査・分析レポートの概要
組換え活性型凝固第VII因子市場の定義
市場セグメント
世界の組換え活性型凝固第VII因子市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の組換え活性型凝固第VII因子市場規模
世界の組換え活性型凝固第VII因子市場規模：2022年 VS 2029年
世界の組換え活性型凝固第VII因子市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの組換え活性型凝固第VII因子の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の組換え活性型凝固第VII因子製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：バイアル、プレフィルドシリンジ
組換え活性型凝固第VII因子のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血友病A、血友病B、その他
組換え活性型凝固第VII因子の用途別グローバル売上・予測

・地域別市場分析
地域別組換え活性型凝固第VII因子市場規模 2022年と2029年
地域別組換え活性型凝固第VII因子売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novo Nordisk、 LFB SA HEMA Biologics、 AryoGen Pharmed
...

Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
This report aims to provide a comprehensive presentation of the global market for Recombinant Activated Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Activated Coagulation Factor VII. This report contains market size and forecasts of Recombinant Activated Coagulation Factor VII in global, including the following market information:
Global Recombinant Activated Coagulation Factor VII Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Activated Coagulation Factor VII Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Recombinant Activated Coagulation Factor VII companies in 2022 (%)
The global Recombinant Activated Coagulation Factor VII market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Activated Coagulation Factor VII include Novo Nordisk, LFB SA HEMA Biologics and AryoGen Pharmed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Activated Coagulation Factor VII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Activated Coagulation Factor VII Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Type, 2022 (%)
Vial
Prefilled Syringe
Global Recombinant Activated Coagulation Factor VII Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Hemophilia B
Other
Global Recombinant Activated Coagulation Factor VII Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Activated Coagulation Factor VII revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Activated Coagulation Factor VII revenues share in global market, 2022 (%)
Key companies Recombinant Activated Coagulation Factor VII sales in global market, 2018-2023 (Estimated), (Units)
Key companies Recombinant Activated Coagulation Factor VII sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Activated Coagulation Factor VII, market overview.
Chapter 2: Global Recombinant Activated Coagulation Factor VII market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Activated Coagulation Factor VII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Activated Coagulation Factor VII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Activated Coagulation Factor VII capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Recombinant Activated Coagulation Factor VII Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Activated Coagulation Factor VII Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Activated Coagulation Factor VII Overall Market Size
2.1 Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2029
2.2 Global Recombinant Activated Coagulation Factor VII Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Activated Coagulation Factor VII Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Activated Coagulation Factor VII Players in Global Market
3.2 Top Global Recombinant Activated Coagulation Factor VII Companies Ranked by Revenue
3.3 Global Recombinant Activated Coagulation Factor VII Revenue by Companies
3.4 Global Recombinant Activated Coagulation Factor VII Sales by Companies
3.5 Global Recombinant Activated Coagulation Factor VII Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Activated Coagulation Factor VII Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Activated Coagulation Factor VII Market Size Markets, 2022 & 2029
4.1.2 Vial
4.1.3 Prefilled Syringe
4.2 By Type – Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
4.2.1 By Type – Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
4.3.1 By Type – Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
4.3.2 By Type – Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
4.3.3 By Type – Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2029
5.1.2 Hemophilia A
5.1.3 Hemophilia B
5.1.4 Other
5.2 By Application – Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
5.2.1 By Application – Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
5.3.1 By Application – Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
5.3.2 By Application – Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
5.3.3 By Application – Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
6.2.1 By Region – Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
6.3.1 By Region – Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
6.3.2 By Region – Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
6.3.3 By Region – Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.4.3 US Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.4.4 Canada Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.4.5 Mexico Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.5.3 Germany Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.4 France Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.5 U.K. Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.6 Italy Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.7 Russia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.9 Benelux Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.6.3 China Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.4 Japan Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.5 South Korea Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.7 India Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.7.3 Brazil Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.7.4 Argentina Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.8.3 Turkey Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.4 Israel Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.6 UAE Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Major Product Offerings
7.1.4 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 LFB SA HEMA Biologics
7.2.1 LFB SA HEMA Biologics Company Summary
7.2.2 LFB SA HEMA Biologics Business Overview
7.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Major Product Offerings
7.2.4 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.2.5 LFB SA HEMA Biologics Key News & Latest Developments
7.3 AryoGen Pharmed
7.3.1 AryoGen Pharmed Company Summary
7.3.2 AryoGen Pharmed Business Overview
7.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Major Product Offerings
7.3.4 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.3.5 AryoGen Pharmed Key News & Latest Developments
8 Global Recombinant Activated Coagulation Factor VII Production Capacity, Analysis
8.1 Global Recombinant Activated Coagulation Factor VII Production Capacity, 2018-2029
8.2 Recombinant Activated Coagulation Factor VII Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Activated Coagulation Factor VII Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Activated Coagulation Factor VII Supply Chain Analysis
10.1 Recombinant Activated Coagulation Factor VII Industry Value Chain
10.2 Recombinant Activated Coagulation Factor VII Upstream Market
10.3 Recombinant Activated Coagulation Factor VII Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Recombinant Activated Coagulation Factor VII in Global Market
Table 2. Top Recombinant Activated Coagulation Factor VII Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Activated Coagulation Factor VII Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Activated Coagulation Factor VII Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Activated Coagulation Factor VII Sales by Companies, (Units), 2018-2023
Table 6. Global Recombinant Activated Coagulation Factor VII Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Activated Coagulation Factor VII Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
Table 9. List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 15. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 16. By Application – Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 20. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 21. By Region – Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 25. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 26. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 29. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 30. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 33. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 34. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 37. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 38. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 41. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Recombinant Activated Coagulation Factor VII Product Offerings
Table 48. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. LFB SA HEMA Biologics Company Summary
Table 51. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Offerings
Table 52. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. LFB SA HEMA Biologics Key News & Latest Developments
Table 54. AryoGen Pharmed Company Summary
Table 55. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Offerings
Table 56. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AryoGen Pharmed Key News & Latest Developments
Table 58. Recombinant Activated Coagulation Factor VII Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 59. Global Recombinant Activated Coagulation Factor VII Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Recombinant Activated Coagulation Factor VII Production by Region, 2018-2023 (Units)
Table 61. Global Recombinant Activated Coagulation Factor VII Production by Region, 2024-2029 (Units)
Table 62. Recombinant Activated Coagulation Factor VII Market Opportunities & Trends in Global Market
Table 63. Recombinant Activated Coagulation Factor VII Market Drivers in Global Market
Table 64. Recombinant Activated Coagulation Factor VII Market Restraints in Global Market
Table 65. Recombinant Activated Coagulation Factor VII Raw Materials
Table 66. Recombinant Activated Coagulation Factor VII Raw Materials Suppliers in Global Market
Table 67. Typical Recombinant Activated Coagulation Factor VII Downstream
Table 68. Recombinant Activated Coagulation Factor VII Downstream Clients in Global Market
Table 69. Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Activated Coagulation Factor VII Segment by Type in 2022
Figure 2. Recombinant Activated Coagulation Factor VII Segment by Application in 2022
Figure 3. Global Recombinant Activated Coagulation Factor VII Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Activated Coagulation Factor VII Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Activated Coagulation Factor VII Revenue in 2022
Figure 9. By Type - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 23. US Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 37. China Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Activated Coagulation Factor VII Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Activated Coagulation Factor VII by Region, 2022 VS 2029
Figure 54. Recombinant Activated Coagulation Factor VII Industry Value Chain
Figure 55. Marketing Channels

※参考情報

組換え活性型凝固第VII因子（Recombinant Activated Coagulation Factor VII、以下、rFVIIa）は、凝固因子の一種であり、特に出血性疾患の治療において重要な役割を果たしています。主に血液凝固を促進する働きを持ち、体内での出血を制御するために使用されます。本稿ではrFVIIaの定義、特徴、種類、用途、関連技術について詳述します。

rFVIIaは、遺伝子組換え技術を用いて製造される活性型の凝固因子VIIです。凝固因子VIIは通常、肝臓で合成されるタンパク質であり、血液中の他の凝固因子と相互作用し、血液の凝固過程において重要な役割を果たします。rFVIIaは、先天的な疾患である血友病Aや血友病B、さらには外傷や手術における重度の出血を対象とした治療法として用いられます。

rFVIIaの特徴として、まず第一に、その迅速な作用が挙げられます。rFVIIaは、投与後短時間で血液の凝固を促進し、出血を止めることができます。これは、細胞外マトリックスや血管内皮と結合し、組織因子との相互作用を通じて他の凝固因子を活性化することによって実現されます。また、rFVIIaは特に出血の際に効力を発揮し、正常な凝固経路が機能しない状況でもその効果を示します。

rFVIIaの種類には、主に2つの製剤が存在します。一つは、特定の患者群に対し、特化した製剤である「Novoseven」（一般名：recombinant activated factor VIIa）です。もう一つは、特定の適応症に対して承認されている他のrFVIIa製剤です。これらは主に、その活性化の仕組みや製造過程に違いがありますが、基本的な治療効果は同様です。

rFVIIaの用途は多岐にわたりますが、代表的なものとしては、血友病患者における出血エピソードの制御があります。血友病AやBにおいては、特定の凝固因子が欠損または機能不全となっているため、出血が続くことがあります。この際にrFVIIaを使用することで、欠損した凝固因子を補完し、出血を迅速に制御することが可能になります。

さらに、rFVIIaは外科手術や外傷に伴う重度の出血の際にも使用されます。特に、大手術や外傷によって急激な出血が発生した場合、従来の治療法では対応が難しいことがありますが、rFVIIaの投与によって迅速に出血を抑えることができます。このような特性により、rFVIIaは緊急医療の現場でも高く評価されています。

関連技術としては、藻類や細菌を用いた新たな製造方法が注目されています。従来の動物由来の製造方法では、感染症のリスクや製剤の安定性に課題がありました。新たな製造技術を活用することによって、より安全で効率的なrFVIIaの製造が可能になることが期待されています。また、遺伝子組換え技術の発展により、より高い活性を持つrFVIIaの発現株の開発も進められています。

最後に、rFVIIaはその効果の一方で、出血リスクを伴う治療法であるため、使用に際しては専門的な知識と経験が要求されることも忘れてはなりません。適切なドシングや投与タイミングを見極めることが、治療の成功において重要なポイントとなります。疾患の特性や患者の状態に応じた個別化医療が、今後ますます重要視されるでしょう。

以上のように、組換え活性型凝固第VII因子は、出血性疾患の治療において重要な役割を果たす医薬品であり、その応用や技術の進展により、さらなる治療の可能性が広がっています。今後の研究と開発が期待される分野であり、医療現場における出血管理の一助となることが求められます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換え活性型凝固第VII因子の世界市場見通し2023年-2029年(Recombinant Activated Coagulation Factor VII Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

組換え活性型凝固第VII因子の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp